We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


SmartDose® Gen. I 3.5mL Drug Delivery Platform

Leading the way with integrated containment and delivery solutions

The first combination product that incorporates the SmartDose® Generation I (Gen. I) drug delivery platform has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose Gen. I device offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.

SmartDose Gen I Logo


  • User loaded, subcutaneous self-administration
  • Ability to deliver high volume and high viscosity drug products 
  • Connectivity capable 
  • Easy to use, intuitive design 
  • Visual, tactile and audible feedback to boost user confidence 
  • Training solutions available for a seamless onboarding experience
  • Address a variety of delivery times through adaptable, pre-programmable technology 
  • Enables less painful injections through pre-programmable delivery times 
  • Multiple published studies* indicate lower pain with customizable delivery rates
  • Installed capacity at multiple manufacturing sites 
  • Regulatory, Quality and Human Factors expertise to support your development

SmartDose Gen I Technical Specifications

SmartDose Gen I Logo









SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc.

West markets SmartDose® as a multi-component system only.  Final assembly of the prefilled component is completed by the pharmaceutical company.

SelfDose™ is a trademark of West Pharmaceutical Services, Inc.